Levisetti Matteo 4
4 · Cue Biopharma, Inc. · Filed Mar 8, 2024
Insider Transaction Report
Form 4
Levisetti Matteo
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-06+260,000→ 260,000 totalExercise: $1.94Exp: 2034-03-05→ Common Stock (260,000 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024.